Skip to main content
Journal of Medical Ethics logoLink to Journal of Medical Ethics
. 2004 Apr;30(2):176–181.

Canaries in the mines: children, risk, non-therapeutic research, and justice

M Spriggs 1
PMCID: PMC1733843  PMID: 15082813

Abstract

The Kennedy Krieger lead paint study received a lot of attention after a US Court of Appeals ruled that a parent cannot consent to the participation of a child in non-therapeutic research. The ruling has raised fears that, if it goes unchallenged, valuable research might not proceed and ultimately all children would be harmed. The author discusses significant aspects of the study that have been neglected, and argues that the study was unethical because it involved injustice and its design meant that the study lacked importance and value. Issues of benefit, risk, and consent are vital, but it is sometimes a mistake to consider these issues before settling questions about justice and the importance and value of a research project. The author concludes by offering a strategy for researchers and reviewers of research to appreciate, in a vivid way, the implications of research participation.

Full Text

The Full Text of this article is available as a PDF (226.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Briefel Gary, Stiff Judith, Nelson Robert. Nontherapeutic research and minimal risk. IRB. 2002 May-Jun;24(3):14–15. [PubMed] [Google Scholar]
  2. Glantz Leonard H. Nontherapeutic research with children: Grimes v Kennedy Krieger Institute. Am J Public Health. 2002 Jul;92(7):1070–1073. doi: 10.2105/ajph.92.7.1070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Kaiser J. Human subjects. Court rebukes Hopkins for lead paint study. Science. 2001 Aug 31;293(5535):1567–1569. doi: 10.1126/science.293.5535.1567b. [DOI] [PubMed] [Google Scholar]
  4. Kopelman Loretta M. Pediatric research regulations under legal scrutiny: Grimes narrows their interpretation. J Law Med Ethics. 2002 Spring;30(1):38–49. doi: 10.1111/j.1748-720x.2002.tb00718.x. [DOI] [PubMed] [Google Scholar]
  5. Lurie P., Wolfe S. M. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. N Engl J Med. 1997 Sep 18;337(12):853–856. doi: 10.1056/NEJM199709183371212. [DOI] [PubMed] [Google Scholar]
  6. Mastroianni Anna C., Kahn Jeffrey P. Risk and responsibility: ethics, Grimes v Kennedy Krieger, and public health research involving children. Am J Public Health. 2002 Jul;92(7):1073–1076. doi: 10.2105/ajph.92.7.1073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Morin K. The standard of disclosure in human subject experimentation. J Leg Med. 1998 Jun;19(2):157–221. doi: 10.1080/01947649809511059. [DOI] [PubMed] [Google Scholar]
  8. Nelson R. M. Nontherapeutic research, minimal risk, and the Kennedy Krieger lead abatement study. IRB. 2001 Nov-Dec;23(6):7–11. [PubMed] [Google Scholar]
  9. Ross Lainie Friedman. In defense of the Hopkins Lead Abatement Studies. J Law Med Ethics. 2002 Spring;30(1):50–57. doi: 10.1111/j.1748-720x.2002.tb00719.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Ethics are provided here courtesy of BMJ Publishing Group

RESOURCES